Normalised Returns
Hospital · closest in market valueAGARWALEYE+0.3%Nifty Pharma+25.7%
Full Comparison
NSE filings · last close| Company | Price | Mkt Cap | P/E | P/B | ROE | Margin | Rev YoY | PAT YoY | D/E | 1Y Rtn |
|---|---|---|---|---|---|---|---|---|---|---|
| MEDANTA | ₹1,495 | ₹40,180 Cr | 72.7× | 10.14× | 15.1% | 12.6% | +26.5% | −1.1% | 0.30× | +13.8% |
| NH | ₹1,861 | ₹38,040 Cr | 46.6× | 8.38× | 19.7% | 10.2% | +78.0% | +5.4% | 1.07× | +5.0% |
| KIMS | ₹780.15 | ₹31,206 Cr | 160.5× | 13.89× | 11.0% | 6.2% | +35.3% | −56.0% | 1.44× | +11.3% |
| AGARWALEYE ● | ₹500 | ₹15,840 Cr | 85.6× | 7.82× | 8.6% | 8.1% | +26.0% | +44.6% | 0.08× | +0.3% |
| RAINBOW | ₹1,374 | ₹13,956 Cr | 48.1× | 8.47× | 18.1% | 16.5% | +33.2% | +16.2% | 0.00× | +2.5% |
| PARKHOSPS | ₹286.35 | ₹12,368 Cr | – | 6.12× | 13.5% | 16.3% | – | – | 0.11× | – |
Hospital: the companies closest in market value, of the 20 in that basic industry whose filings we hold, from each company's NSE filings and the last close. Quarterly figures are for Q1 FY27; ROE, margin for FY26; P/B and D/E on the latest balance sheet. Green and red mark the two ends of a column; valuation and leverage columns are left plain. Hover a heading for its definition.
Against Hospital20 companies
P/E84.9×
18.2×median 62.9× · 4 of 17, highest first319.9×
P/B7.76×
1.56×median 7.28× · 9 of 18, highest first14.9×
ROE9.1%
2.5%median 12.1% · 12 of 17, highest first25.4%
Net margin8.4%
1.3%median 10.2% · 12 of 17, highest first16.7%
Revenue growth—
6.5%median 17.5% · 15 companies57.8%
Profit growth—
-51.9%median 8.0% · 14 companies33.2%
Debt / equity0.08×
0.00×median 0.27× · 14 of 18, highest first1.44×
Dividend yield—
0.0%median 0.2% · 12 companies1.6%
1-year price change3.2%
-41.4%median 6.5% · 10 of 17, highest first48.6%
Everyone in Hospital whose filings we hold: 20 companies, its basic industry within Healthcare. Figures as the screener works them out (the last four quarters' profit, the latest balance sheet, the last close), so ROE can differ a little from the Financials tab's latest-year figure. A place in the line is a fact about a number, not a view on the company.
AGARWALEYE Rankings
Among 6 companies compared
Profitability
6
ROE 8.6%Lowest of 65
Net margin 8.1%5th highest of 6Growth
5
Revenue YoY +26.0%Lowest of 51
Net profit YoY +44.6%Highest of 5Leverage
2
Debt / equity 0.08×2nd lowest of 6Valuation
4
P/E 85.6×4th lowest of 52
P/Book 7.82×2nd lowest of 6Price
5
1-year return +0.3%Lowest of 5Position 1 is the lowest NPA, multiple or leverage, and the highest return, growth or profitability figure. These are positions among the companies listed here, not a view on the stock.